Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA

Blood

Volumn 111, Issue 3, 2008, Pages 1234-1239

  Peterson, Julie A ^a   Nelson, Tamara N ^a   Kanack, Adam J ^a   Aster, Richard H ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; EPITOPE; GLYCOPROTEIN IIIA; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AP3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RAT;

EID: 38949177435     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-09-112680     Document Type: Article

References (40)

1. Aster RH, BougieDW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580-587.
2. Rizvi MA, Shah SR, Raskob GE, George JN. Drug-induced thrombocytopenia. Curr Opin Hematol. 1999;6:349-353.
3. Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol. 1999;36:2-6.
4. Shulman NR, Reid DM. Mechanisms of drug-induced immunologically mediated cytopenias. Transfus Med Rev. 1993;7:215-229.
5. Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol. 2005;42:137-144.
6. Stroncek DF. Drug-induced immune neutropenia. Transfus Med Rev. 1993;7:268-274.
7. Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev. 1990;4:69-77.
8. Kunicki TJ, Russell N, Nurden AT, Aster RH, Caen JP. Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. J Immunol. 1981;126:398-402.
9. Christie DJ, Mullen PC, Aster RH. Quinine- and quinidine platelet antibodies can react with GPIIb/IIIa. Br J Haematol. 1987;67:213-219.
10. Chong BH, Du XP, Berndt MC, Horn S, Chesterman CN. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies. Blood. 1991;77:2190-2199.
11. Visentin GP, Newman PJ, Aster RH. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood. 1991;77:2668-2676.
12. Peterson JA, Nyree CE, Newman PJ, Aster RH. A site involving the "hybrid" and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia. Blood. 2003;101:937-942.
13. Newman PJ, McEver RP, Doers MP, Kunicki TJ. Synergistic action of two murine monoclonal antibodies that inhibit ADP-induced platelet aggregation without blocking fibrinogen binding. Blood. 1987;69:668-676.
14. Honda S, Tomiyama Y, Pelletier AJ, et al. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit. J Biol Chem. 1995;270:11947-11954.
15. Xiong JP, Stehle T, Zhang R, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science. 2002;296:151-155.
16. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol. 2007;25:619-647.
17. Humphries MJ, Mould AP. Structure: an anthropomorphic integrin. Science. 2001;294:316-317.
18. Michael NP, Chester KA, Melton RG, et al. In vitro and in vivo characterisation of a recombinant carboxy-peptidase G2::anti-CEA scFv fusion protein. Immunotechnology. 1996;2:47-57.
19. Grimaldi CM, Chen F, Scudder LE, Coller BS, French DL. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia. Blood. 1996;88:1666-1675.
20. Granados R, Guoxun L, Derksen ACG, McKenna KA. Trichoplusia ni (B11-Tn-SB1-4) susceptible to Trichoplusia single enveloped nuclear polyhedrosis virus. J Invertebr Pathol. 1994;64:260-266.
21. Wickham TJ, Davis T, Granados RR, Shuler ML, Wood HA. Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system. Biotechnol Prog. 1992;8:391-396.
22. Davis TR, Wickham TJ, McKenna KA, Granados RR, Shuler ML, Wood HA. Comparative recombinant protein production of eight insect cell lines. In Vitro Cell Dev Biol Anim. 1993;29:388-390.
23. Yin J, Li G, Ren X, Herrler G. Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol. 2007;127:335-347.
24. Wendeler M, Lemm T, Weisgerber J, et al. Expression of recombinant human GM2-activator protein in insect cells: purification and characterization by mass spectrometry. Protein Expr Purif. 2003;27:259-266.
25. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 1989;83:1778-1781.
26. Valentin N, Visentin GP, Newman PJ. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Blood. 1995;85:3028-3033.
27. Burgess JK, Lopez JA, Berndt MC, Dawes I, Chesterman CN, Chong BH. Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes. Blood. 1998;92:2366-2373.
28. Asvadi P, Ahmadi Z, Chong BH. Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies. Blood. 2003;102:1670-1677.
29. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673-4680.
30. Thompson JD, Higgins DG, Gibson TJ. Improved sensitivity of profile searches through the use of sequence weights and gap excision. Comput Appl Biosci. 1994;10:19-29.
31. Huizinga EG, Tsuji S, Romijn RA, et al. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science. 2002;297:1176-1179.
32. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A. 1997;94:7589-7594.
33. Xiong JP, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 2001;294:339-345.
34. Christie DJ, Aster RH. Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia. J Clin Invest. 1982;70:989-998.
35. Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug- specific" antibodies. Blood. 2006;108:922-927.
36. Shulman NR. A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in auto-immunity: Combined Clinical Staff Conference at the National Institutes of Health. Ann Intern Med. 1964;60:506-521.
37. Christie DJ, Weber RW, Mullen PC, Cook JM, Aster RH. Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets. J Lab Clin Med. 1984;104:730-740.
38. Wanwimolruk S, Denton JR. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria. J Pharm Pharmacol. 1992;44:806-811.
39. Frostell-Karlsson A, Remaeus A, Roos H, et al. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J Med Chem. 2000;43:1986-1992.
40. Bougie DW, Birenbaum J, Ahl S, Aster RH. Monoclonal antibodies that mimic antibodies found in patients with drug [quinine(qn)]-induced immune thrombocytopenia (DITP): implications for the pathogenesis of DITP [abstract]. J Thromb Haemost. 2007;5:30.